- Supported exchanges /
- SHG /
- 688336.SHG
Sunshine Guojian Pharmaceutical Shanghai Co Ltd (688336 SHG) stock market data APIs
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of antibody drugs in China. Its products include YISAIPU, a tumor necrosis factor inhibitor for rheumatism; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody injection; Cipterbin, an anti-HER2 monoclonal antibody. The company is also developing products for autoimmune diseases, tumors, and other diseases. The company was founded in 2002 and is based in Shanghai, China.
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Financial Data Overview
22.98 | |
23.87 | |
- | |
24.58 | |
22.97 | |
15.1919-26.6664 | |
13 323 M | |
40 | |
617 M | |
1 074 M | |
0.0543 | |
0.0024 | |
0.303 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Sunshine Guojian Pharmaceutical Shanghai Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 074 M
- EBITDA 338 M
- Earnings Per Share 0.54
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Sunshine Guojian Pharmaceutical Shanghai Co Ltd Earnings via APIs
- Latest Release 2023-03-31
- EPS/Forecast NaN
Get Sunshine Guojian Pharmaceutical Shanghai Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: